1. Monroy-Cuadros M., Yilmaz S., Salazar-Banuelos A., Doig C. Risk factors associated with patency loss of hemodialysis vascular access within 6 months. Clinical Journal of the American Society of Nephrology: CJASN. 2010; 5(10): 1787–1792.
2. Gumilevskaya O.P., Vakhaniya K.P. Polimorfizm genov faktorov svertyvaniya u patsientov gemodializa s retsidiviruyushchimi trombozami arteriovenoznykh fistul. Vestnik Volgogradskogo gosudarstvennogo meditsinskogo universiteta. 2013; 4(48): 36–38.
3. Ram S., Bass K., Abreo K., et al. Tumor necrosis factor-α-308 gene polymorphism is associated with synthetic hemodialysis graft failure. J. Invest. Med. 2017; 51(1): 19–26.
4. Altuntas A., Yigit A., Uz E. The relationship between serum fetuin a levels and fetuin gene polymorphism in hemodialysis patients. Biomedical Research. 2017; 28(2): 495–502.
5. Lin C.-C., Yang W.-C., Chung M.-Y., et al. Functional polymorphisms in matrix Metalloproteinases-1, –3, –9 are associated with arteriovenous fistula patency in hemodialysis patients. CJASN. 2010; 5(10): 1805–1814.